Legend Biotech Appoints Ingrid Zhang Chief Executive

Company: Legend Biotech · Event Type: Executive Appointment · New CEO: Ingrid Zhang · Context: Permanent Succession Following Interim CEO Period · Date: September 15, 2026 Summary Legend Biotech appointed Ingrid Zhang chief executive officer and principal executive officer effective September 15, 2026, following a…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Pfizer – SF R&D Site Closure
Tempus Acquires Personalis for $1.5 Billion
PTC Therapeutics Wins $211M Bankruptcy Auction for Sangamo’s Fabry Disease Gene Therapy
Waypoint Bio – China IIT CAR-T Strategy